Financials
Financial year 2025
MV PHARMA from Saint-Ghislain, company number BE0673532069, closed financial year 2025 with a result of € 15,733 after tax. For that financial year MV PHARMA recorded a gross margin of € 23,202 and equity of € 426,143. Compared with financial year 2024, the result moved from € 1,534 to € 15,733. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 26, 2026.
€ 426,143
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,733
▲ € 14,200 vs 2024
Profit after tax over the fiscal year.
€ 2,957
▼ 89% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 405,683.
People and assets in 2025
€ 3,363
▲ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,591
▲ € 6,309 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,915
▲ 214% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 68,311 | € 73,005 | € 4,210 | € 23,202 | ▲ € 18,992 |
| Profit after taxes | € 45,118 | € 46,686 | € 1,534 | € 15,733 | ▲ € 14,200 |
| Equity | € 362,189 | € 408,876 | € 410,410 | € 426,143 | ▲ 4% |
| Total debts | € 517,739 | € 73,203 | € 45,982 | € 43,044 | ▼ 6% |
| Cash | € 11 | € 113,627 | € 26,617 | € 2,957 | ▼ 89% |
| Retained profit | € 343,589 | € 388,416 | € 389,950 | € 405,683 | ▲ 4% |
| Bank debt | € 449,128 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 879,928 | € 482,079 | € 456,392 | € 469,186 | ▲ 3% |
Key figures of MV PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MV PHARMA?
What happened at MV PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,733 (▲ € 14,200 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- VALENTINE MAGREZ became a director. NBB
In short
From € 45,118 profit in 2022 to € 15,733 profit in 2025.
Paid € 31,417 in corporate taxes since 2022.
Best year ever: 2023, with € 46,686 profit.
Management
Behind MV PHARMA is VALENTINE MAGREZ. It owns 100% of MV IMMOBILIER itself.
Directors
According to the 2025 annual accounts
since 2017
Establishments
Establishment units
Physical locations of this company
Rue des Juifs(B) 94
7331 Saint-Ghislain
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0673.532.069
- VAT number
- BE 0673.532.069
- Registered office
- Rue des Juifs(B) 94, 7331 Saint-Ghislain
- Names & denominations
- MV PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 March 2017
- Peppol
- Active · Active since 1 Oct 2025
- Contact
- [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten